The roles of neutral sphingomyelinases in neurological pathologies (Q37975165)

26 August 2017

The roles of neutral sphingomyelinases in neurological pathologies (English)

1 reference

26 August 2017

0 references

Charles R Horres

1

1 reference

PubMed ID

22237969

26 August 2017

Yusuf A Hannun

series ordinal

2

1 reference

PubMed ID

22237969

26 August 2017

language of work or name

1 reference

12 January 2012

1 reference

26 August 2017

Neurochemical Research

1 reference

26 August 2017

37

1 reference

26 August 2017

6

1 reference

26 August 2017

1137-1149

1 reference

https://scigraph.springernature.com/pub.10.1007/s11064-011-0692-y

26 August 2017

0 references

cites work

Principles of bioactive lipid signalling: lessons from sphingolipids

1 reference

https://api.crossref.org/works/10.1007%2FS11064-011-0692-Y

Ceramide regulation of apoptosis versus differentiation: a walk on a fine line. Lessons from neurobiology

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11064-011-0692-Y

Characterization of common SMPD1 mutations causing types A and B Niemann-Pick disease and generation of mutation-specific mouse models

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11064-011-0692-Y

Mammalian neutral sphingomyelinases: regulation and roles in cell signaling responses

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11064-011-0692-Y

Cloned mammalian neutral sphingomyelinase: functions in sphingolipid signaling?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11064-011-0692-Y

Characterization and subcellular localization of murine and human magnesium-dependent neutral sphingomyelinase

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11064-011-0692-Y

Neutral sphingomyelinase 1 deficiency in the mouse causes no lipid storage disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11064-011-0692-Y

Novel tumor necrosis factor-responsive mammalian neutral sphingomyelinase-3 is a C-tail-anchored protein

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11064-011-0692-Y

Neutral sphingomyelinase-3 is a DNA damage and nongenotoxic stress-regulated gene that is deregulated in human malignancies

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11064-011-0692-Y

Cloning and characterization of the mammalian brain-specific, Mg2+-dependent neutral sphingomyelinase

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11064-011-0692-Y

Inhibition of tumor necrosis factor-induced cell death in MCF7 by a novel inhibitor of neutral sphingomyelinase

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11064-011-0692-Y

Biochemical properties of mammalian neutral sphingomyelinase 2 and its role in sphingolipid metabolism

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11064-011-0692-Y

Neutral sphingomyelinase 2 (nSMase2) is the primary neutral sphingomyelinase isoform activated by tumour necrosis factor-α in MCF-7 cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11064-011-0692-Y

The Polycomb group protein EED couples TNF receptor 1 to neutral sphingomyelinase

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11064-011-0692-Y

FAN, a novel WD-repeat protein, couples the p55 TNF-receptor to neutral sphingomyelinase

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11064-011-0692-Y

Interaction with factor associated with neutral sphingomyelinase activation, a WD motif-containing protein, identifies receptor for activated C-kinase 1 as a novel component of the signaling pathways of the p55 TNF receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11064-011-0692-Y

Anterograde and retrograde transport of neutral sphingomyelinase-2 between the Golgi and the plasma membrane

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11064-011-0692-Y

Role for mammalian neutral sphingomyelinase 2 in confluence-induced growth arrest of MCF7 cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11064-011-0692-Y

Stress-induced sphingolipid signaling: role of type-2 neutral sphingomyelinase in murine cell apoptosis and proliferation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11064-011-0692-Y

Neutral sphingomyelinase 2 (smpd3) in the control of postnatal growth and development

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11064-011-0692-Y

Neutral sphingomyelinase (SMPD3) deficiency causes a novel form of chondrodysplasia and dwarfism that is rescued by Col2A1-driven smpd3 transgene expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11064-011-0692-Y

A cell-autonomous requirement for neutral sphingomyelinase 2 in bone mineralization

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11064-011-0692-Y

Involvement of oxidative stress-induced abnormalities in ceramide and cholesterol metabolism in brain aging and Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11064-011-0692-Y

Accumulation of long-chain glycosphingolipids during aging is prevented by caloric restriction.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11064-011-0692-Y

Neuronal endosomal/lysosomal membrane destabilization activates caspases and induces abnormal accumulation of the lipid secondary messenger ceramide.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11064-011-0692-Y

Oxidative stress kills human primary oligodendrocytes via neutral sphingomyelinase: implications for multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11064-011-0692-Y

Tumor necrosis factor-alpha-induced neutral sphingomyelinase-2 modulates synaptic plasticity by controlling the membrane insertion of NMDA receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11064-011-0692-Y

NMDA receptor trafficking in synaptic plasticity and neuropsychiatric disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11064-011-0692-Y

Regulation of ceramide-induced neuronal death: cell metabolism meets neurodegeneration.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11064-011-0692-Y

Ceramide-mediated insulin resistance and impairment of cognitive-motor functions

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11064-011-0692-Y

Ordering of ceramide formation, caspase activation, and Bax/Bcl-2 expression during etoposide-induced apoptosis in C6 glioma cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11064-011-0692-Y

Ceramide and activated Bax act synergistically to permeabilize the mitochondrial outer membrane

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11064-011-0692-Y

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11064-011-0692-Y

Role of membrane lipids in regulation of vulnerability to oxidative stress in PC12 cells: implication for aging

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11064-011-0692-Y

Glutathione metabolism during aging and in Alzheimer disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11064-011-0692-Y

Age-associated perturbations in glutathione synthesis in mouse liver

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11064-011-0692-Y

Overexpression of glutamate-cysteine ligase extends life span in Drosophila melanogaster

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11064-011-0692-Y

Dopamine release in PC12 cells is mediated by Ca(2+)-dependent production of ceramide via sphingomyelin pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11064-011-0692-Y

Ceramide inhibits axonal growth and nerve growth factor uptake without compromising the viability of sympathetic neurons

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11064-011-0692-Y

A TrkA-to-p75NTR molecular switch activates amyloid beta-peptide generation during aging

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11064-011-0692-Y

Nitrosamine exposure exacerbates high fat diet-mediated type 2 diabetes mellitus, non-alcoholic steatohepatitis, and neurodegeneration with cognitive impairment

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11064-011-0692-Y

Acute-phase proteins in Alzheimer's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11064-011-0692-Y

Brain interleukin 1 and S-100 immunoreactivity are elevated in Down syndrome and Alzheimer disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11064-011-0692-Y

Elevated circulating tumor necrosis factor levels in Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11064-011-0692-Y

Microglia and neuroinflammation: a pathological perspective

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11064-011-0692-Y

Alteration in the activation state of new inflammation-associated targets by phospholipase A2-activating protein (PLAA)

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11064-011-0692-Y

Phospholipase A(2), reactive oxygen species, and lipid peroxidation in CNS pathologies

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11064-011-0692-Y

Interleukin-1 and neuronal injury: mechanisms, modification, and therapeutic potential

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11064-011-0692-Y

Interleukin-6-associated inflammatory processes in Alzheimer's disease: new therapeutic options.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11064-011-0692-Y

Alzheimer's disease is not "brain aging": neuropathological, genetic, and epidemiological human studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11064-011-0692-Y

Amyloid plaque core protein in Alzheimer disease and Down syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11064-011-0692-Y

Intracellular amyloid-beta in Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11064-011-0692-Y

Long-chain ceramide is elevated in presenilin 1 (PS1M146V) mouse brain and induces apoptosis in PS1 astrocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11064-011-0692-Y

Fibrillar amyloid-beta peptides kill human primary neurons via NADPH oxidase-mediated activation of neutral sphingomyelinase. Implications for Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11064-011-0692-Y

Amyloid-beta peptide induces oligodendrocyte death by activating the neutral sphingomyelinase-ceramide pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11064-011-0692-Y

Neutral sphingomyelinase activation in endothelial and glial cell death induced by amyloid beta-peptide

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11064-011-0692-Y

Sphingomyelinase dependent apoptosis of dendritic cells following treatment with amyloid peptides

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11064-011-0692-Y

Deregulation of sphingolipid metabolism in Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11064-011-0692-Y

Amyloid-β and tau--a toxic pas de deux in Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11064-011-0692-Y

Amyloid-beta peptide enhances tumor necrosis factor-alpha-induced iNOS through neutral sphingomyelinase/ceramide pathway in oligodendrocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11064-011-0692-Y

Amyloid beta peptide increases DP5 expression via activation of neutral sphingomyelinase and JNK in oligodendrocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11064-011-0692-Y

Ceramide stabilizes beta-site amyloid precursor protein-cleaving enzyme 1 and promotes amyloid beta-peptide biogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11064-011-0692-Y

Connection of lipid peroxide oxidation with the sphingomyelin pathway in the development of Alzheimer's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11064-011-0692-Y

Substantial sulfatide deficiency and ceramide elevation in very early Alzheimer's disease: potential role in disease pathogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11064-011-0692-Y

Practice parameter: diagnosis of dementia (an evidence-based review). Report of the Quality Standards Subcommittee of the American Academy of Neurology

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11064-011-0692-Y

Biomarkers predicting Alzheimer's disease in cognitively normal aging

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11064-011-0692-Y

Reduced effectiveness of Abeta1-42 immunization in APP transgenic mice with significant amyloid deposition.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11064-011-0692-Y

HIV infection of the central nervous system: clinical features and neuropathogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11064-011-0692-Y

HIV-1 associated dementia: symptoms and causes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11064-011-0692-Y

Human immunodeficiency virus (HIV) proteins in neuropathogenesis of HIV dementia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11064-011-0692-Y

Novel markers of oxidative stress in actively progressive HIV dementia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11064-011-0692-Y

Perturbation of sphingolipid metabolism and ceramide production in HIV-dementia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11064-011-0692-Y

Human immunodeficiency virus type 1 gp120 induces apoptosis in human primary neurons through redox-regulated activation of neutral sphingomyelinase

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11064-011-0692-Y

Proinflammatory cytokines and HIV-1 synergistically enhance CXCL10 expression in human astrocytes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11064-011-0692-Y

Role of the pro-inflammatory cytokines TNF-alpha and IL-1beta in HIV-associated dementia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11064-011-0692-Y

Immunologic NO synthase: elevation in severe AIDS dementia and induction by HIV-1 gp41.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11064-011-0692-Y

Cellular localization of tumor necrosis factor mRNA in neurological tissue from HIV-infected patients by combined reverse transcriptase/polymerase chain reaction in situ hybridization and immunohistochemistry.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11064-011-0692-Y

Prevention of disabling and fatal strokes by successful carotid endarterectomy in patients without recent neurological symptoms: randomised controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11064-011-0692-Y

Carotid plaque pathology: thrombosis, ulceration, and stroke pathogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11064-011-0692-Y

Inflammation and atherosclerosis: novel insights into plaque formation and destabilization

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11064-011-0692-Y

Mechanisms of plaque vulnerability and rupture

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11064-011-0692-Y

Increased expression of matrix metalloproteinases and matrix degrading activity in vulnerable regions of human atherosclerotic plaques

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11064-011-0692-Y

Role for matrix metalloproteinase-2 in oxidized low-density lipoprotein-induced activation of the sphingomyelin/ceramide pathway and smooth muscle cell proliferation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11064-011-0692-Y

Role for furin in tumor necrosis factor alpha-induced activation of the matrix metalloproteinase/sphingolipid mitogenic pathway.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11064-011-0692-Y

Plaque rupture is a determinant of vascular events in carotid artery atherosclerotic disease: involvement of matrix metalloproteinases 2 and 9.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11064-011-0692-Y

Vascular proliferation and atherosclerosis: new perspectives and therapeutic strategies.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11064-011-0692-Y

Secretory mechanisms and intercellular transfer of microRNAs in living cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11064-011-0692-Y

Delivery of microRNA-126 by apoptotic bodies induces CXCL12-dependent vascular protection

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11064-011-0692-Y

JNK3 signaling pathway activates ceramide synthase leading to mitochondrial dysfunction.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11064-011-0692-Y

Production and metabolism of ceramide in normal and ischemic-reperfused myocardium of rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11064-011-0692-Y

N-tosyl-L-phenylalanyl-chloromethyl ketone reduces ceramide during hypoxic-ischemic brain injury in newborn rat.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11064-011-0692-Y

Sphingomyelinase-induced ceramide production stimulate calcium-independent JNK and PP2A activation following cerebral ischemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11064-011-0692-Y

Factor associated with neutral sphingomyelinase activation and its role in cardiac cell death

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11064-011-0692-Y

Delayed hypothermia prevents decreases in N-acetylaspartate and reduced glutathione in the cerebral cortex of the neonatal pig following transient hypoxia-ischaemia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11064-011-0692-Y

Relation between myocardial glutathione content and extent of ischemia-reperfusion injury

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11064-011-0692-Y

Myocardial glutathione depletion impairs recovery after short periods of ischemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11064-011-0692-Y

Glutathione deficiency intensifies ischaemia-reperfusion induced cardiac dysfunction and oxidative stress.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11064-011-0692-Y

Inhibition of sphingomyelinase activity helps to prevent neuron death caused by ischemic stress

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11064-011-0692-Y

Treatment of hypoxic-ischemic brain injury in newborn rats with TPCK 3 h after hypoxia decreases caspase-9 activation and improves neuropathologic outcome

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11064-011-0692-Y

Ceramide generated by sphingomyelin hydrolysis and the salvage pathway is involved in hypoxia/reoxygenation-induced Bax redistribution to mitochondria in NT-2 cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11064-011-0692-Y

Involvement of ceramide in ischemic tolerance induced by preconditioning with sublethal oxygen-glucose deprivation in primary cultured cortical neurons of rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11064-011-0692-Y

Pivotal role of the cell death factor BNIP3 in ceramide-induced autophagic cell death in malignant glioma cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11064-011-0692-Y

Mutations in the neutral sphingomyelinase gene SMPD3 implicate the ceramide pathway in human leukemias

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11064-011-0692-Y

Comparative epigenomics of human and mouse mammary tumors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11064-011-0692-Y

Overexpression of the EGF receptor and p53 mutations are mutually exclusive in the evolution of primary and secondary glioblastomas.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11064-011-0692-Y

p53 regulates ceramide formation by neutral sphingomyelinase through reactive oxygen species in human glioma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11064-011-0692-Y

Molecular mechanisms of TNF-alpha-induced ceramide formation in human glioma cells: P53-mediated oxidant stress-dependent and -independent pathways

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11064-011-0692-Y

p53 disruption profoundly alters the response of human glioblastoma cells to DNA topoisomerase I inhibition

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11064-011-0692-Y

Nerve growth factor, sphingomyelins, and sensitization in sensory neurons

21 January 2018

1 reference

12 December 2020

Inhibition of neutral sphingomyelinase activation and ceramide formation by glutathione in hypoxic PC12 cell death

1 reference

12 December 2020

Intrathecal and serum interleukin-6 and the acute-phase response in patients with severe traumatic brain injuries

1 reference

12 December 2020

Cell death in HIV dementia

1 reference

12 December 2020

Activation of sphingolipid turnover and chronic generation of ceramide and sphingosine in liver during aging

1 reference

12 December 2020

Role of sphingosine 1-phosphate in the mitogenesis induced by oxidized low density lipoprotein in smooth muscle cells via activation of sphingomyelinase, ceramidase, and sphingosine kinase

1 reference

12 December 2020

Myelin contains neutral sphingomyelinase activity that is stimulated by tumor necrosis factor-alpha.

1 reference

12 December 2020

Rapid activation of neutral sphingomyelinase by hypoxia-reoxygenation of cardiac myocytes

1 reference

12 December 2020

Ceramide is involved in triggering of cardiomyocyte apoptosis induced by ischemia and reperfusion

1 reference

12 December 2020

Soluble oligomers of amyloid-beta peptide induce neuronal apoptosis by activating a cPLA2-dependent sphingomyelinase-ceramide pathway

1 reference

12 December 2020

Lipid rafts in the maintenance of synapses, dendritic spines, and surface AMPA receptor stability.

1 reference

12 December 2020

Ceramide prevents neuronal programmed cell death induced by nerve growth factor deprivation

1 reference

12 December 2020

Inhibitory effects of C apolipoproteins from rats and humans on the uptake of triglyceride-rich lipoproteins and their remnants by the perfused rat liver

1 reference

12 December 2020

Glucosylceramide synthase activity and ceramide levels are modulated during cerebral ischemia after ischemic preconditioning

1 reference

12 December 2020

Cytosolic phospholipase A2 mediates neuronal apoptosis induced by soluble oligomers of the amyloid-beta peptide

1 reference

12 December 2020

A deletion in the gene encoding sphingomyelin phosphodiesterase 3 (Smpd3) results in osteogenesis and dentinogenesis imperfecta in the mouse

1 reference

12 December 2020

Hypoxic preconditioning protects cultured neurons against hypoxic stress via TNF-alpha and ceramide.

1 reference

12 December 2020

Effect of overexpression of a neutral sphingomyelinase on CD95-induced ceramide production and apoptosis

1 reference

12 December 2020

Incidence and timing of p53 mutations during astrocytoma progression in patients with multiple biopsies.

1 reference

12 December 2020

Inhibition of neutral sphingomyelinase-2 perturbs brain sphingolipid balance and spatial memory in mice

1 reference

12 December 2020

Sphingomyelin changes in rat cerebral cortex during focal ischemia.

1 reference

12 December 2020

Lethal forebrain ischemia stimulates sphingomyelin hydrolysis and ceramide generation in the gerbil hippocampus

1 reference

12 December 2020

HIV infection and dementia

1 reference

12 December 2020

Apolipoprotein C-I induces apoptosis in human aortic smooth muscle cells via recruiting neutral sphingomyelinase

1 reference

12 December 2020

Carotid endarterectomy for asymptomatic carotid stenosis

1 reference

12 December 2020

Structural requirements for catalysis and membrane targeting of mammalian enzymes with neutral sphingomyelinase and lysophospholipid phospholipase C activities. Analysis by chemical modification and site-directed mutagenesis

1 reference

12 December 2020

Changes of sphingolipids profiles after ischemia-reperfusion injury in the rat liver.

1 reference

12 December 2020

Ceramide signaling downstream of the p75 neurotrophin receptor mediates the effects of nerve growth factor on outgrowth of cultured hippocampal neurons.

1 reference

12 December 2020

MAO-A-induced mitogenic signaling is mediated by reactive oxygen species, MMP-2, and the sphingolipid pathway

1 reference

12 December 2020

Assessment of amyloid beta-protein precursor gene mutations in a large set of familial and sporadic Alzheimer disease cases

1 reference

12 December 2020

Apolipoprotein C-I modulates the interaction of apolipoprotein E with beta-migrating very low density lipoproteins (beta-VLDL) and inhibits binding of beta-VLDL to low density lipoprotein receptor-related protein

1 reference

12 December 2020

10.1007/S11064-011-0692-Y

Identifiers

DOI

1 reference

26 August 2017

1 reference

PubMed ID

22237969